HHS and HRSA Defend 340B Discount Model Against Pharma Rebate Plan
By EsqSocial Corporation 02/04/25
Summary of Changes - In the fall of 2024, several pharmaceutical companies – specifically, Eli Lilly and Company, Sanofi-Aventis U.S. LLC, Bristol Myers Squibb Company, and Novartis Pharmaceuticals Corporation – reacted to HRSA's decision to prevent them from implementing a rebate model for their respective 340B Programs by filing lawsuits against HHS and HRSA claiming that the Department and its subagency violated their rights under the Administrative Procedure Act and took actions that...
By: Baker Donelson